Fatigue: an important feature of late-onset Pompe disease

被引:48
作者
Hagemans, Marloes L. C.
van Schie, Sabine P. M.
Janssens, A. Cecile J. W.
Van Doorn, Pieter A.
Reuser, Arnold J. J.
van der Ploeg, Ans T.
机构
[1] Erasmus MC Sophia, Div Metab Dis & Genet, Dept Paediat, NL-3015 GJ Rotterdam, Netherlands
[2] Erasmus MC, Dept Publ Hlth, NL-3015 GJ Rotterdam, Netherlands
[3] Erasmus MC, Dept Neurol, NL-3015 GE Rotterdam, Netherlands
[4] Erasmus MC, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands
关键词
Pompe disease; alpha-glucosidase; lysosomal storage disorder; myopathy; Fatigue Severity Scale;
D O I
10.1007/s00415-006-0434-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To investigate the prevalence and severity of fatigue in adult patients with Pompe disease. Methods The Fatigue Severity Scale (FSS) was assessed in an international population of 225 adults with Pompe disease, a metabolic disorder presenting as a slowly progressive proximal myopathy. The FSS scores were compared to those of healthy controls and the relationship between the level of fatigue and other patient characteristics was investigated. Results The mean age of the participants was 47 (SD 13) years and the mean disease duration 11 (SD 8) years. 43% used a wheelchair and 46% had respiratory support, 29% needed both. 67% of the participants had a FSS score >= 5, indicating severe fatigue. The mean FSS score was 5.2 (SD 1.5), which was significantly higher than that of healthy controls (p < 0.001). Fatigue was not related to age, sex or disease duration. Patients who used a wheelchair or respiratory support were on average more fatigued than those who did not (p = 0.01). However, of the patients who did not use these aids, 59% also had a FSS score >= 5. FSS scores were highest among patients who reported a high frequency of sleep disorders, but patients who never experienced sleep difficulties were also fatigued (mean FSS score = 4.8). Conclusion Fatigue is highly prevalent among both mildly and severely affected adult patients with Pompe disease. The FSS appears a useful tool in assessing fatigue in Pompe disease.
引用
收藏
页码:941 / 945
页数:5
相关论文
共 32 条
[1]   Fatigue in obstructive sleep apnea: Driven by depressive symptoms instead of apnea severity.? [J].
Bardwell, WA ;
Moore, P ;
Ancoli-Israel, S ;
Dimsdale, JE .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (02) :350-355
[2]   Cross-cultural differences in health-related quality of life of people with epilepsy: Findings from a European study [J].
Buck, D ;
Jacoby, A ;
Baker, GA ;
Ley, H ;
Steen, N .
QUALITY OF LIFE RESEARCH, 1999, 8 (08) :675-685
[3]   Fatigue in neurological disorders [J].
Chaudhuri, A ;
Behan, PO .
LANCET, 2004, 363 (9413) :978-988
[4]   Correlation between physical performance and fatigue in cancer patients [J].
Dimeo, F ;
Stieglitz, RD ;
Novelli-Fischer, U ;
Fetscher, S ;
Mertelsmann, R ;
Keul, J .
ANNALS OF ONCOLOGY, 1997, 8 (12) :1251-1255
[5]   The assessment of fatigue - A practical guide for clinicians and researchers [J].
Dittner, AJ ;
Wessely, SC ;
Brown, RG .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2004, 56 (02) :157-170
[6]  
Engel AG, 1994, MYOLOGY BASIC CLIN, P1533
[7]   Cytokine mRNA expression in patients with multiple sclerosis and fatigue [J].
Flachenecker, P ;
Bihler, I ;
Weber, F ;
Gottschalk, M ;
Toyka, KV ;
Rieckmann, P .
MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (02) :165-169
[8]   Fatigue in multiple sclerosis:: a comparison of different rating scales and correlation to clinical parameters [J].
Flachenecker, P ;
Kümpfel, T ;
Kallmann, B ;
Gottschalk, M ;
Grauer, O ;
Rieckmann, P ;
Trenkwalder, C ;
Toyka, K .
MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (06) :523-526
[9]   Physical training and fatigue, fitness, and quality of life in Guillain-Barr syndrome and CIDP [J].
Garssen, MPJ ;
Bussmann, JBJ ;
Schmitz, PIM ;
Zandbergen, A ;
Welter, TG ;
Merkies, ISJ ;
Stam, HJ ;
van Doorn, PA .
NEUROLOGY, 2004, 63 (12) :2393-2395
[10]   Disease severity in children and adults with Pompe disease related to age and disease duration [J].
Hagemans, MLC ;
Winkel, LPF ;
Hop, WCJ ;
Reuser, AJJ ;
Van Doorn, PA ;
Van der Ploeg, AT .
NEUROLOGY, 2005, 64 (12) :2139-2141